auto_awesome
Want to know who else bid on this?
ProposalForge correlates this contract with the original RFP, the losing bidders, and the next recompete window.
Recipient
Northern RNA Inc.Amount
$15.0M
Program
SIF Stream 2 - GrowthProvince
ABType
Contribution
Agreement Number
033-2023-2024-Q2-819504
Purpose
This project will establish a good manufacturing practice (GMP)-ready Chemical Manufacturing Facility at the Edmonton Research Park in Edmonton, Alberta. The facility will provide commercial-scale chemical manufacturing capacity focused on the production of lipids and other critical pharmaceutical materials used in advanced therapeutics, vaccines, and lipid nanoparticle (LNP) systems.The project’s work phase is scheduled to end on March 31, 2029.
Northern RNA Inc. × Innovation, Science and Economic Development Canada
5 grants totalling $57.4M
SIF Stream 2 - Growth
20 grants totalling $1.4B
Related Grants
| Recipient | Amount | Program |
|---|---|---|
| Air Products Canada Ltd. | $300.0M | SIF Stream 2 - Growth |
| Resilience Biotechnologies Inc. | $199.2M | SIF Stream 2 - Growth |
| AbCellera Biologics Inc. | $175.6M | SIF Stream 2 - Growth |
| Linamar Corporation | $169.4M | SIF Stream 2 - Growth |
| ArcelorMittal Mining Canada G.P.|ArcelorMittal Exploitation Minière Canada s.e.n.c. | $125.0M | SIF Stream 2 - Growth |